Cargando…

SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA

Detalles Bibliográficos
Autores principales:	Flower, Barnaby, Atchison, Christina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518795/ https://www.ncbi.nlm.nih.gov/pubmed/32987009 http://dx.doi.org/10.1016/S0140-6736(20)32006-7

Ejemplares similares

SARS-CoV-2 seroprevalence in COVID-19 hotspots
por: Eckerle, Isabella, et al.
Publicado: (2020)

Estimating SARS-CoV-2 seroprevalence in long-term care: a window of opportunity
por: Verschoor, Chris P, et al.
Publicado: (2022)

Antibodies, epicenter of SARS-CoV-2 immunology
por: Pecetta, Simone, et al.
Publicado: (2021)

SARS-CoV-2 Lambda and Gamma variants competition in Peru, a country with high seroprevalence
por: Vargas-Herrera, Natalia, et al.
Publicado: (2021)

Dissecting antibody-mediated protection against SARS-CoV-2
por: Zohar, Tomer, et al.
Publicado: (2020)

Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma
por: Lim, Sean H, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 Antibodies in Children and Adults in St. Louis, Missouri, USA
por: Smith, Brittany K., et al.
Publicado: (2021)

SARS-CoV-2 Antibody Seroprevalence Among Maintenance Dialysis Patients in the United States
por: Walker, Adam G., et al.
Publicado: (2021)

Lack of detail in population-level data impedes analysis of SARS-CoV-2 variants of concern and clinical outcomes
por: Ong, Sean Wei Xiang, et al.
Publicado: (2021)

Systemic lupus erythematosus does not prevent antibody responses to SARS-CoV-2
por: Aringer, Martin
Publicado: (2021)

WHO international standard for SARS-CoV-2 antibodies to determine markers of protection
por: Zhu, Feng, et al.
Publicado: (2022)

SARS-CoV-2 vaccine-induced antibody levels: what lies beneath
por: Lassaunière, Ria, et al.
Publicado: (2022)

Antibody responses induced by Sputnik V vaccine in individuals previously infected with SARS-CoV-2
por: Raiden, Silvina, et al.
Publicado: (2021)

SARS-CoV-2 structural features may explain limited neutralizing-antibody responses
por: Bachmann, Martin F., et al.
Publicado: (2021)

B cells: more than just for antibodies in SARS-CoV-2 vaccine responses
por: Paley, Michael A, et al.
Publicado: (2021)

Neutralizing antibodies and their cocktails against SARS-CoV-2 Omicron and other circulating variants
por: Yang, Yang, et al.
Publicado: (2022)

Impact of anti-PEG antibodies induced by SARS-CoV-2 mRNA vaccines
por: Ju, Yi, et al.
Publicado: (2022)

Asymptomatic SARS-CoV-2 infection
por: Ooi, Eng Eong, et al.
Publicado: (2020)

The complexities of SARS-CoV-2 serology
por: Houlihan, Catherine F, et al.
Publicado: (2020)

Neonatal SARS-CoV-2 infection
por: de Carvalho, Werther Brunow, et al.
Publicado: (2020)

Towards SARS-CoV-2 serotypes?
por: Simon-Loriere, Etienne, et al.
Publicado: (2022)

Sustained neutralising antibodies in the Wuhan population suggest durable protection against SARS-CoV-2
por: Strugnell, Richard, et al.
Publicado: (2021)

Did Laos really control the transmission of SARS-CoV-2 in 2020?
por: Flower, Barnaby, et al.
Publicado: (2021)

Bell's palsy and SARS-CoV-2 vaccines
por: Ozonoff, Al, et al.
Publicado: (2021)

Understanding the drivers of transmission of SARS-CoV-2
por: Cornelissen, Laura, et al.
Publicado: (2021)

SARS-CoV-2 vaccination in people with HIV
por: Spinelli, Matthew A
Publicado: (2021)

Optimising SARS-CoV-2 vaccination schedules
por: Belda-Iniesta, Cristobal
Publicado: (2021)

The SARS-CoV2 pandemic and routine immunisation
por: Kang, Gagandeep
Publicado: (2022)

Sustainability of surveillance systems for SARS-CoV-2
por: Adlhoch, Cornelia, et al.
Publicado: (2022)

Immunosuppression and SARS-CoV-2 breakthrough infections
por: Kim, Alfred H J, et al.
Publicado: (2022)

Decoding the next SARS-CoV-2 variant
por: Nel, Jeremy, et al.
Publicado: (2022)

Diabetes after SARS-CoV-2 infection
por: Al-Aly, Ziyad
Publicado: (2023)

SARS-CoV-2 infection and cardiac arrhythmias
por: Dewland, Thomas A., et al.
Publicado: (2022)

SARS-CoV-2 rebound with and without antivirals
por: Petrosillo, Nicola
Publicado: (2023)

Impact of contact tracing on SARS-CoV-2 transmission
por: Sun, Kaiyuan, et al.
Publicado: (2020)

Who is most likely to be infected with SARS-CoV-2?
por: Jordan, Rachel E, et al.
Publicado: (2020)

SARS-CoV-2: virus dynamics and host response
por: Chen, Yu, et al.
Publicado: (2020)

Persistence of IgG response to SARS-CoV-2
por: Duysburgh, Els, et al.
Publicado: (2021)

Tracking SARS-CoV-2 infection in India with serology
por: John, Jacob, et al.
Publicado: (2021)

Correlates of protection from SARS-CoV-2 infection
por: Krammer, Florian
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ekdu4vfdojh2f03o1mc8295gqb